DULAGLUTIDE AND CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES (REWIND): A DOUBLE-BLIND, RANDOMISED PLACEBO-CONTROLLED TRIAL ArticleGerstein H.C., Dyal L., Hall S., Rao-Melacini P., Wong G., Colhoun H.M., Dagenais G.R., Diaz R., Lakshmanan M., Riesmeyer J.S., Atisso C.M., Pais P., Xavier D., Probstfield J., Riddle M.C., Rydén L., Avezum A., Basile J., Chung N., Conget I. ...Lancet. Том 394. 2019. С. 121-130
PRE-DISCHARGE ANEMIA AS A PREDICTOR OF ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE ArticleKim M.C., Kim K.H., Cho J.Y., Lee K.H., Sim D.S., Yoon H.J., Yoon N.S., Hong Y.J., Park H.W., Kim J.H., Ahn Y., Jeong M.H., Cho J.G., Park J.C.The Korean Journal of Internal Medicine. Том 34. 2019. С. 549-558
